Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension (CRF Survey)
5. august 2026 opdateret af: Nathaphong Dejthida, DejthidaNathaphong
Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension (CRF Survey)
To evaluate both sides of the common carotid artery, renal artery, and femoral artery in Hypertension patient that cause of systemic arterial hypertension and/or the effects of target organ damage, both structural and functional markers.
Studieoversigt
Status
Ikke rekrutterer endnu
Intervention / Behandling
Detaljeret beskrivelse
The study of the first degree, both sides in some of the aortic branch group, the effect and/or cause of systemic arterial hypertension compared to normotension. According to the theory of systemic arterial hypertension, the arterial resistance and high blood volume flow causing systemic arterial hypertension, the cause of arterial resistance and high blood volume flow evaluation may trace back to the possible actual cause of systemic arterial hypertension by backward investigation. Despite the fact that target organ damage is the crucial maneuver of hypertension evaluation, both sides of the common carotid artery, renal artery, and femoral artery may cause systemic arterial hypertension and may imply that feasible to predict the end organ of stroke, ESRD, and amputated-type arterial occlusion, respectively.
This study belongs to 2 questions
- Can the main aortic branch be evidence of a cause of systemic arterial hypertension following high resistance and/or high fluid flow by theory?
- Can the main aortic branch be a marker of evidence of endpoint organ damage?
Undersøgelsestype
Observationel
Tilmelding (Anslået)
100
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Nathaphong Dejthida, Medical Degree
- Telefonnummer: +66819220662
- E-mail: bnnatto@gmail.com
Studiesteder
-
-
Bangkok
-
Vadhana, Bangkok, Thailand, 10110
- Invstigation center
-
Kontakt:
- Nathaphong Dejthida, Medical Degree
- Telefonnummer: 0819220662
- E-mail: bnnatto@gmail.com
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Hypertensive patient who underwent the radiographic measurement of structure and function of carotid artery, renal artery or femoral artery
Beskrivelse
Inclusion Criteria:
- Adults ≥18 years with diagnosed hypertension by a clinician, both untreated and treated, including successfully treated participants.
Imaging evidence of at least 1 list of
- Common carotid artery
- Renal artery
- Femoral artery
Exclusion Criteria:
- Fatal pathology and imaging
- Pediatric or pregnant participants
- Small vessel angiogram
- Intravascular endoscopy
- Intra-operative estimation
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Common Carotid Artery
The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Common Carotid Artery.
|
Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery
Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s)
|
|
Renal Artery
The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Renal Artery.
|
Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery
Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s)
|
|
Femoral Artery
The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Femoral Artery.
|
Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery
Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s)
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Median of diameter of common carotid artery, renal artery and femoral artery in hypertension patients.
Tidsramme: 1 years
|
Radiographic measurement includes ultrasonography, CT/MR imaging, and intravascular contrast media imaging that measure the diameter in cm. unit of any side of common carotid artery and/or renal artery and/or femoral artery in hypertension patients.
|
1 years
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Common Carotid Artery Function
Tidsramme: 1 year
|
Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Common Carotid Artery
|
1 year
|
|
Renal Artery Function
Tidsramme: 1 year
|
Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Renal Artery
|
1 year
|
|
Femoral Artery Function
Tidsramme: 1 year
|
Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Femoral Artery
|
1 year
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
All-cause mortality outcomes
Tidsramme: 1 year
|
Incidence of mortality rate (case per 1,000 person-year) of hypertensive participants were underwent measurement the diameter one side of one of common carotid artery and/or renal artery and/or femoral artery
|
1 year
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Hjælpsomme links
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
1. august 2026
Primær færdiggørelse (Anslået)
31. december 2026
Studieafslutning (Anslået)
18. maj 2027
Datoer for studieregistrering
Først indsendt
30. juli 2026
Først indsendt, der opfyldte QC-kriterier
5. august 2026
Først opslået (Faktiske)
12. august 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
12. august 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
5. august 2026
Sidst verificeret
1. august 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- NathaphongD
- PROSPERO (Anden identifikator: CRD420261464383)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .